60204 Federal Register / Vol. 65, No. 196 / Tuesday, October 10, 2000 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Medication Development Research.

Date: November 2, 2000.

Time: 10 am to 12 pm.

Agenda: To review and evaluate grant

applications.

Place: Hyatt—Arlington at Washington’s

Key Bridge, 1325 Wilson Boulevard,

Arlington, VA 22209–9990.

Contact Person: Mark Swieter, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1389.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Medication Development Research.

Date: November 2, 2000.

Time: 12:30 pm to 1:30 pm.

Agenda: To review and evaluate grant

applications.

Place: Hyatt—Arlington at Washington’s

Key Bridge, 1325 Wilson Boulevard,

Arlington, VA 22209–9990.

Contact Person: Mark Swieter, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1389.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Program, National Institutes of Health, HHS)

Dated: September 29, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25885 Filed 10–06–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as pententable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of person privacy.

Name of Committee: National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel.

Date: October 27, 2000.

Time: 8:30 am to 1 pm.

Agenda: To review and evaluate contract

proposals.

Place: Gaithersburg Holiday Inn,

Gaithersburg, MD 20879.

Contact Person: Vassil S. Georgiev,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2217, 6700–B

Rockledge Drive, MSC, 7610, Bethesda, MD

20892–7610, 301–496–2550.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: September 29, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25888 Filed 10–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 13, 2000.

Time: 11:00 AM to 12:30 PM.

Agenda: To review and evaluate grant

applications.

Place: Governor’s House Hotel,

Washington, DC 20036.

Contact Person: Anita Miller Sostek, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3176,

MSC 7848, Bethesda, MD 20892, (301) 435–

1260

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group, Integrative,

Functional and Cognitive Neuroscience 8.

Date: October 19–20, 2000.

Time: 8:00 AM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Samuel Rawlings, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5160,

MSC 7844, Bethesda, MD 20892, (301) 435–

1243.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 19–20, 2000.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Yvette M. Davis, VmD,

MpH, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 3152, MSC 7770, Bethesda, MD 20892,

301–435–0906.

Name of Committee: Molecular, Cellular

and Developmental Neuroscience Integrated

Review Group, Visual Sciences C Study

Section.

Date: October 19–20, 2000.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Santa Fe, 4048

Cerrillos Road, Santa Fe, NM 87505.

Contact Person: Carole L. Jelsema, PhD,

Chief, MDCN Scientific Review Group,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 5210, MSC 7850, Bethesda, MD 20892,

(301) 435–1248, jelsemac@csr.nih.gov.

Federal Register / Vol. 65, No. 196 / Tuesday, October 10, 2000 / Notices 60205

Name of Committee: Immunological

Sciences Integrated Review Group Allergy

and Immunology Study Section.

Date: October 19–20, 2000.

Time: 8:30 AM to 5:00 PM

Agenda: To review and evaluate grant

applications.

Place: Wyndham City Center, 1143 New

Hampshire Avenue, NW, Washington, DC

20037.

Contact Person: Eugene M. Zimmerman,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4202,

MSC 7812, Bethesda, MD 20892, 301–435–

1220.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 19–20, 2000.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Savoy Suites Georgetown, 2505

Wisconsin Avenue, N.W., Washington, DC

20007.

Contact Person: Michele C. HindiAlexander, PhD, Scientific Review

Administrator, Center for Scientific Review,

National Institutes of Health, 6701 Rockledge

Drive, Room 4188 MSC 7848, Bethesda, MD

20892, 301–435–3554.

Name of Committee: Oncological Sciences

Integrated Review Group, Experimental

Therapeutics Subcommittee 1.

Date: October 19–20, 2000.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Arlington Hyatt, 1325 Wilson

Boulevard, Arlington, VA 22209

Contact Person: Philip Perkins, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4148,

MSC 7804, Bethesda, MD 20892, (301) 435–

1718, perkinsp@csr.nih.gov.

Name of Committee: Biophysical and

Chemical Sciences Integrated Review Group,

Biophysical Chemistry Study Section.

Date: October 19–20, 2000.

Time: 8:30 AM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Ramada Hotel Bethesda, 8400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Arnold Revzin, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4192,

MSC 7806, Bethesda, MD 20892, (301) 435–

1153.

Name of Committee: Cell Development and

Function Integrated Review Group, Cell

Development and Function 5.

Date: October 19–20, 2000.

Time: 8:30 AM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Ramesh K. Nayak, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5146,

MSC 7840, Bethesda, MD 20892, (301) 435–

1026.

Name of Committee: Biochemical Sciences

Intergrated Review Group, Biochemistry

Study Section.

Date: October 19–20, 2000.

Time: 8:30 AM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Chhanda L. Ganguly, PhD.,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5156,

MSC 7842, Bethesda, MD 20892, (301) 435–

1739.

Name of Committee: Cell Development and

Function Integrated Review Group,

International and Cooperative Projects Study

Section.

Date: October 19–20, 2000.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Sandy Warren, DmD, Mph,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5134,

MDC 7840, Bethesda, MD 20892, (301) 435–

1019.

Name of Committee: Cell Development and

Function Integrated Review Group, Cell

Development and Function 4.

Date: October 19–20, 2000.

Time: 8:30 AM to 12:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Marcia Steinberg, PhD.,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5140,

MSC 7840, Bethesda, MD 20892, (301) 435–

1023.

Name of Committee: Infectious Diseases

and Microbiology Integrated Review Group,

Microbial Physiology and Genetics

Subcommittee 2.

Date: October 19–20, 2000.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Suites, 1111 30th Street,

NW, Washington, DC 20007.

Contact Person: Rona L. Hirschberg, PhD.,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4186,

MSC 7808, Bethesda, MD 20892, (301) 435–

1150.

Name of Committee: Immunological

Sciences Integrated Review Group,

Immunobiology Study Section.

Date: October 19–20, 2000.

Time: 9:30 AM to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Palladian West, Chevy Chase, MD

20815.

Contact Person: Betty Hayden, PhD.,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4206,

MSC 7812, Bethesda, MD 20892, (301) 435–

1223.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 19–20, 2000.

Time: 9:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: State Plaza Hotel 2117 E Street

Washington, DC 20037

Contact Person: Carl D. Banner, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5212,

MSC 7850, Bethesda, MD 20892, (301) 435–

1251, bannerc@drg.nih.gov

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 19, 2000.

Time: 11:00 AM to 2:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: John Bishop, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5180,

MSC 7844, Bethesda, MD 20892, (301) 435–

1250.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 19–20, 2000.

Time: 9:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mariana Dimitrov, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3180,

MSC 7848, Bethesda, MD 20892, (301) 435–

0902.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 20, 2000.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Washington Court Hotel, 525 New

Jersey Avenue, N.W., Washington, DC 20001.

Contact Person: Nancy Hicks, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive Room 3158,

MSC 7770, Bethesda, MD 20892.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: October 20, 2000.

Time: 2:00 PM to 3:00 PM.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Dennis Leszczynski, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 6170,

MSC 7892, Bethesda, MD 20892, (301) 435–

1044.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

60206 Federal Register / Vol. 65, No. 196 / Tuesday, October 10, 2000 / Notices

Dated: October 3, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25879 Filed 10–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Toxicology Program; National

Institute of Environmental Health

Sciences; Center for the Evaluation of

Risks to Human Reproduction

Announces the Availability of Seven

Expert Panel Reports on Phthalate

Esters and Solicits Public Comments

on These Reports

Background

The National Toxicology Program

(NTP) and the National Institute of

Environmental Health Sciences have

established the NTP Center for the

Evaluation of Risks to Human

Reproduction (CERHR; December 14,

1998 [63 FR 68782]). The purpose of the

Center is to provide timely and

unbiased, scientifically sound

evaluations of human and experimental

evidence for adverse effects on

reproduction, including development,

caused by agents to which humans may

be exposed. The goals of the individual

assessments are to (1) interpret for and

provide to the general public

information about the strength of

scientific evidence that a given exposure

or exposure circumstance may pose a

hazard to reproduction and the health

and welfare of children: (2) provide

regulatory agencies with objective and

scientifically thorough assessments of

the scientific evidence that adverse

reproductive/development health effects

are associated with exposure to specific

chemicals or classes of chemicals,

including descriptions of any

uncertainties that would diminish

confidence in assessment of risks, and

(3) identify knowledge gaps to help

establish research and testing priorities.

Phthalate Esters Reviewed

This evaluation of seven phthalate

esters was conducted over a one year

period by a 16-member Expert Panel

made up of scientists from government,

universities, and industry (May 23, 2000

[65 FR 33343–33345]). Public

deliberations by the Panel were

completed in July, 2000. Since that

time, the draft reports have been revised

to incorporate the conclusions reached

by the Panel in their July, 2000, meeting

and have been reviewed for accuracy by

the CERHR Core Committee, made up of

representatives of NTP-participating

agencies, NTP scientists, and members

of the Phthalates Expert Panel. Phthalate

esters are used as plasticizers in a wide

range of polyvinyl chloride-based

consumer products. These phthalate

esters were selected for the initial

evaluation by the CERHR based on their

high production volume, extent of

human exposures, use in children’s

products, published evidence of

reproductive or developmental toxicity,

and public concern.

The following phthalate esters were

reviewed by CERHR (Chemical Abstract

Service Registry Number):

butyl benzyl phthalate (85–68–7)

di(2-ethylhexyl) phthalate (117–81–7)

di-isodecyl phthalate (26761–40–0,

68515–49–1)

di-isononyl phthalate (28553–12–0,

68515–48–0)

di-n-butyl phthalate (84–74–2)

di-n-hexyl phthalate (84–75–3)

di-n-octyl phthalate (117–84–0)

Availability of Phthalate Reports

Expert Panel reports on the above

phthalate esters can be obtained from

the CERHR website http://

cerhr.niehs.nih.gov). Hard copies can be

obtained by contacting: Ms. Harriet

McCullom, Management Coordinator,

CERHR, 1800 Diagonal Road, Suite 500,

Alexandria, VA 22314–2808,

Telephone: 703–838–9440, Facsimile:

703–684–2223.

Request for Public Comment on the

Expert Panel Reports

The Center invites public comment on

the Expert Panel Reports listed above,

including any recent relevant toxicology

data and human exposure information.

These reports are the product of the

Expert Panel review of data available as

of July 1, 2000. Public comments

received on the Expert Panel Reports

will be reviewed, summarized, and

included in the NTP Center transmittal

report prepared by the NTP staff. NTP

will transmit the NTP Center report, the

Expert Panel Report, the public

comments received on the expert panel

report, and any new information since

completion of the expert panel report to

the appropriate Federal and State

Agencies, the public, and the scientific

community. Further information on the

Center’s chemical review process can be

obtained from the CERHR website

(http://cerhr.niehs.nih.gov).

Written comments received by

December 11, 2000 will be considered.

Please forward comments and chemical

information to: Michael D. Shelby,

Ph.D.; Director, CERHR, NIEHS/NTP

B3–09; P.O. Box 12233; Research

Triangle Park, NC 27709–2233;

Telephone: 919–541–3455; Facsimile:

919–541–4634.

Dated: October 2, 2000.

Samuel H. Wilson,

Deputy Director, NIEHS.

[FR Doc. 00–25892 Filed 10–6–00; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[AZ–040–00–1040–XX]

Gila Box Riparian National

Conservation Area (RNCA) Advisory

Committee Meeting

AGENCY: Bureau of Land Management,

Interior.

SUMMARY: The purpose of this notice is

to announce the next meeting of the Gila

Box Riparian National Conservation

Area Advisory Committee Meeting. The

purpose of the Advisory Committee is to

provide informed advice to the Bureau

of Land Management (BLM) Safford

Field Manager on management of public

lands in the Gila Box Riparian National

Conservation Area. The committee

meets as needed, generally between two

and four times a year.

The meeting will begin at the BLM

Safford Field Office on November 3,

2000, commencing at 7 a.m. and ending

at 5 p.m. The meeting’s agenda will

consist of a tour of portions of the Gila

Box RNCA with community leaders

from Graham and Greenlee counties to

build support for the implementation of

the Gila Box RNCA management plan. A

public comment period will begin at 7

a.m. and may continue for the duration

of the meeting at the discretion of the

Gila Box Advisory Committee. The

public may accompany the Committee

and invited guests on the tour, but must

provide their own transportation and

lunch.

DATES: Meeting will be held on

November 3, 2000, starting at 7 a.m.

FOR FURTHER INFORMATION CONTACT: Jon

Collins, Gila Box RNCA Project

Coordinator, BLM, Safford Field Office,

711 14th Avenue, Safford, Arizona

85546; telephone number: (520) 348–

4400.

Dated: September 28, 2000.

Wayne King,

Acting Field Office Manager.

[FR Doc. 00–25911 Filed 10–6–00; 8:45 am]

BILLING CODE 4310–22–M